The Problem |
|
The
|
A locally acting novel formulation of volatile general anesthetics which are administered topically at or near the site of peripheral pain. Results from a Phase 2 Clinical Study of VPX638 demonstrated rapid and prolonged pain relief resulting in a reduction or elimination of chronic opioid use while also avoiding systemic side effects.
|
Encouraging results from our Phase II Clinical Study of VPX638
Our plans to develop a new class of medications to reduce pain
|
What's new: Keep up with our progress
|